Clinical Trial Club: Navtemadlin Vs Best Available Therapy In Relapsed Or Refractory Myelofibrosis
Synopsis
On July 19, 2022, Scientific Education Support held its first clinical trial club, entitled “BOREAS trial: Navtemadlin (KRT-232) vs ...
You Might Also Like
Download Options
Choose a download method below. All links open in new tabs.
| Service | Features | Action |
|---|---|---|
| SaveFrom |
MP4 & MP3 • HD Quality • Browser Extension Available
|
Download |
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.